Asan Medical Center

This study tests three different flu vaccines in 60 adults with blood cancers like leukemia or lymphoma, including those who had a stem cell transplant or CAR-T therapy. The goal is to see which vaccine triggers the strongest immune response. Results will help doctors choose the …

This study tests a combination of two drugs, rivoceranib and paclitaxel, in people with advanced gastrointestinal stromal tumors (GIST) that have a specific marker (high P-glycoprotein) and have stopped responding to three standard treatments. The goal is to see if this combo can…

This study tests whether adding the drug cilostazol to standard anti-clotting therapy can reduce early stroke recurrence in people who had a stroke due to narrowed arteries in the brain or neck. About 2,340 adults will receive either standard care or standard care plus cilostazol…

This study tests whether a personalized blood-thinning plan (shorter dual therapy followed by one drug alone) is safer and just as effective as the standard approach for people with coronary artery disease who have received a stent guided by imaging. About 3,944 adults will be fo…

This study tests the chemotherapy drug temozolomide in people with advanced gastrointestinal stromal tumors (GIST) that lack a certain enzyme (SDH deficiency). About 29 adults will receive the drug to see if it shrinks tumors and controls the disease. The goal is to offer a new t…

This study is for people with advanced solid cancers that stopped responding to standard immunotherapy. It tests whether a fecal microbiota transplant (FMT) — transferring healthy gut bacteria from a donor — combined with the drug nivolumab can shrink tumors. About 50 participant…

This study tests an oral form of paclitaxel (Liporaxel) in 28 adults with advanced gastrointestinal stromal tumors (GIST) that no longer respond to three standard treatments. The goal is to see if the drug can control tumor growth for at least 16 weeks. Participants must have low…

This study tests whether giving a combination of three chemotherapy drugs (docetaxel, oxaliplatin, and S-1) before surgery can help remove stomach cancer that has spread to nearby tissues or lymph nodes. About 63 adults with advanced stomach cancer that cannot be fully removed by…

This study tests a combination of three drugs (lenvatinib, nivolumab, and chemotherapy) in people with advanced stomach cancer that has spread and caused fluid buildup in the belly. The goal is to see if this treatment can shrink tumors and help patients live longer without the c…

This study tests a new drug called Irpagratinib combined with two existing cancer drugs (Atezolizumab and Bevacizumab) for people with advanced liver cancer that cannot be removed by surgery. The goal is to see if the combination is safe and shrinks tumors. About 33 adults with a…

This study tests the drug lenvatinib in people with advanced gastrointestinal stromal tumors (GIST) that have stopped responding to three standard treatments. The goal is to see if lenvatinib can shrink or stabilize the tumors and to check for side effects. About 48 adults will t…

This study compares two ways to program pacemakers in people with slow heart rhythms. Researchers want to see if a newer method (Left Bundle Branch Area Pacing) is better than a standard method (Minimized Ventricular Pacing) at preventing death, heart failure hospital stays, and …

This study is testing a wearable heart monitor (MEMO Patch) to see if it can find hidden atrial fibrillation—an irregular heartbeat that raises stroke risk—in 100 people who had a stroke with no known cause. Participants wear the patch for up to 14 days at home, and doctors check…

This study is testing whether a special PET scan called FES PET/CT can better detect cancer that has spread to distant parts of the body in people with a certain type of stage III breast cancer. The cancer must be low-grade and estrogen receptor-positive. About 85 adults will rec…

This study tests whether a shorter, safer MRI scan can find returning liver cancer as well as the usual CT scan. It involves 455 adults who have been cancer-free for at least two years after treatment. The goal is to reduce radiation and contrast dye risks while still catching ca…

This study tests whether giving iron through a vein (IV ferric carboxymaltose) can safely improve anemia in people with advanced stomach cancer who are receiving palliative chemotherapy. About 330 adults will take part. The main goal is to see if the iron treatment raises hemoglo…

This study tests whether a smartphone-based rehab platform can help adults who were in the intensive care unit (ICU) for more than 48 hours regain strength and thinking skills. About 70 participants from two hospitals in South Korea will use the app daily for up to 30 minutes. Re…

This study follows 400 people with mitral stenosis who are getting a balloon procedure to open their heart valve. Researchers want to see how well the treatment works and find the best balloon size to use. The goal is to improve care for future patients.

This study follows over 500 adults with type 2 diabetes who had a heart CT scan years ago. Researchers will repeat the scan to see how plaque builds up in heart arteries over time and identify factors that increase risk. The goal is to better understand heart disease in diabetes,…

This study aims to understand how the immune system and genes change in people with advanced liver cancer during immunotherapy. Researchers will collect blood and tumor samples from 50 participants before, during, and after treatment. The goal is to find biomarkers that predict h…